Daniel Grosslight
Stock Analyst at Citigroup
(1.27)
# 3,605
Out of 4,959 analysts
102
Total ratings
37.7%
Success rate
-12.3%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Buy | $11 → $7 | $5.05 | +38.61% | 7 | Aug 12, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $6.5 → $3.5 | $3.28 | +6.71% | 10 | Aug 8, 2025 | |
| AGL agilon health | Downgrades: Neutral | $3 → $1 | $1.33 | -24.81% | 6 | Aug 6, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $45 | $36.24 | +24.17% | 1 | Jun 25, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $157 → $170 | $148.10 | +14.79% | 9 | Jun 13, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $44.57 | -32.69% | 11 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $7.68 | +13.93% | 11 | Apr 25, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $9.60 | +87.50% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.56 | +37.06% | 7 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $689.45 | -1.81% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $29.75 | +17.65% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $21.97 | +13.79% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $3.84 | +160.42% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $10.40 | -23.08% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.69 | -53.53% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.80 | +25.00% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.61 | +35.28% | 1 | Dec 11, 2019 |
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $5.05
Upside: +38.61%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $6.5 → $3.5
Current: $3.28
Upside: +6.71%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $1.33
Upside: -24.81%
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $36.24
Upside: +24.17%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157 → $170
Current: $148.10
Upside: +14.79%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $44.57
Upside: -32.69%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $7.68
Upside: +13.93%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $9.60
Upside: +87.50%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.56
Upside: +37.06%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $689.45
Upside: -1.81%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $29.75
Upside: +17.65%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $21.97
Upside: +13.79%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $3.84
Upside: +160.42%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $10.40
Upside: -23.08%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.69
Upside: -53.53%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.80
Upside: +25.00%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.61
Upside: +35.28%